Skip to main content
logo
Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
5.79
-0.02 (-0.34%)
At close: May 15, 2026, 4:00 PM EDT
5.75
-0.04 (-0.69%)
After-hours: May 15, 2026, 4:10 PM EDT

Quoin Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1000000
Market Cap Growth
53.57%271.36%20.50%-29.11%-54.61%131.71%
Enterprise Value
-1.43-17.99-13.42-10.06-12.21-6.78
Last Close Price
5.7914.4322.78171.68596.409555.00
PE Ratio
--0.97-11.93-17.81-12.740.00
PB Ratio
1.190.010.000.010.010.16
P/TBV Ratio
1.071.182.6427.3116.250.08
P/FCF Ratio
---0.010.00-0.01-0.02
P/OCF Ratio
---0.010.00-0.01-0.02
EV/EBITDA Ratio
-1.101.421.081.331.14
EV/EBIT Ratio
-1.101.411.071.321.12
EV/FCF Ratio
--1.711.281.441.18
Debt / Equity Ratio
0.070.050.070.110.080.91
Debt / EBITDA Ratio
-0.03-0.04-0.06-0.06-0.07-0.10
Debt / FCF Ratio
---0.08-0.08-0.07-0.10
Net Debt / Equity Ratio
-1.53-1.38-1.46-1.78-1.65-10.48
Net Debt / EBITDA Ratio
0.771.111.431.091.341.16
Net Debt / FCF Ratio
--1.711.281.451.20
Quick Ratio
2.633.383.362.993.641.64
Current Ratio
2.873.613.573.153.791.79
Return on Equity (ROE)
-154.97%-141.66%-120.55%-132.92%-232.68%721.40%
Return on Assets (ROA)
-96.80%-90.25%-68.36%-70.44%-77.75%-112.96%
Return on Invested Capital (ROIC)
545.94%622.96%554.69%662.76%606.78%483.04%
Return on Capital Employed (ROCE)
-138.66%-123.54%-94.73%-96.10%-117.85%663.86%
Earnings Yield
-162.69%-102.56%-8.38%-5.62%-7.85%-42675.00%
FCF Yield
-0.00%-19280.10%-23253.10%-17774.80%-5442.26%
Buyback Yield / Dilution
-0.00%-18.56%-346.38%-3834446.75%-31.42%
Total Shareholder Return
-0.00%-18.56%-346.38%-3834446.75%-31.42%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q